Titomic Limited engages in additive manufacturing activities in Australia.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.28|
|52 Week High||AU$0.28|
|52 Week Low||AU$0.71|
|1 Month Change||-8.20%|
|3 Month Change||-30.00%|
|1 Year Change||-58.82%|
|3 Year Change||-82.28%|
|5 Year Change||n/a|
|Change since IPO||-37.78%|
Recent News & Updates
|TTT||AU Chemicals||AU Market|
Return vs Industry: TTT underperformed the Australian Chemicals industry which returned 12.9% over the past year.
Return vs Market: TTT underperformed the Australian Market which returned 20.2% over the past year.
Stable Share Price: TTT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: TTT's weekly volatility (7%) has been stable over the past year.
About the Company
Titomic Limited engages in additive manufacturing activities in Australia. The company focuses on the development and commercialization of the Titomic Kinetic Fusion (TKF) process, an additive manufacturing technology that is used for the application of cold-gas dynamic spraying of titanium or titanium alloy particles onto a scaffold to produce a load-bearing structure. It provides metal powders for additive manufacturing; TKF manufacturing systems, which offers rapid and agile manufacturing, prototyping, custom parts, and pilot runs; TKF bureau manufacturing provides industrial-scale additive manufacturing service.
Titomic Fundamentals Summary
|TTT fundamental statistics|
Is TTT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TTT income statement (TTM)|
|Cost of Revenue||AU$1.56m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.11|
|Net Profit Margin||-865.28%|
How did TTT perform over the long term?See historical performance and comparison
Is Titomic undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TTT (A$0.28) is trading below our estimate of fair value (A$4.68)
Significantly Below Fair Value: TTT is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TTT is unprofitable, so we can't compare its PE Ratio to the Australian Chemicals industry average.
PE vs Market: TTT is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TTT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TTT is overvalued based on its PB Ratio (4.5x) compared to the AU Chemicals industry average (4x).
How is Titomic forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TTT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: TTT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TTT's is expected to become profitable in the next 3 years.
Revenue vs Market: TTT's revenue (74.1% per year) is forecast to grow faster than the Australian market (5.4% per year).
High Growth Revenue: TTT's revenue (74.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TTT's Return on Equity is forecast to be low in 3 years time (0.2%).
How has Titomic performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TTT is currently unprofitable.
Growing Profit Margin: TTT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TTT is unprofitable, and losses have increased over the past 5 years at a rate of 46.2% per year.
Accelerating Growth: Unable to compare TTT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TTT is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-61.8%).
Return on Equity
High ROE: TTT has a negative Return on Equity (-181.91%), as it is currently unprofitable.
How is Titomic's financial position?
Financial Position Analysis
Short Term Liabilities: TTT's short term assets (A$11.1M) exceed its short term liabilities (A$3.0M).
Long Term Liabilities: TTT's short term assets (A$11.1M) exceed its long term liabilities (A$1.2M).
Debt to Equity History and Analysis
Debt Level: TTT is debt free.
Reducing Debt: TTT has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TTT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TTT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.4% each year
What is Titomic current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TTT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TTT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TTT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TTT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TTT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Herbert Koeck (60 yo)
Mr. Herbert Koeck has been Chief Executive Officer of Titomic Limited since July 1, 2021. He served as Executive Vice President of Global Go To Market at 3D Systems Corporation until September 15, 2020. Mr...
Experienced Management: TTT's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Experienced Board: TTT's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Titomic Limited's employee growth, exchange listings and data sources
- Name: Titomic Limited
- Ticker: TTT
- Exchange: ASX
- Founded: 2014
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: AU$42.910m
- Shares outstanding: 153.25m
- Website: https://www.titomic.com
- Titomic Limited
- Building 3
- 270 Ferntree Gully Road
- Notting Hill
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/20 15:34|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.